|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.850 USD | -2.32% |
|
-5.09% | -67.41% |
| 07-08 | Seres Therapeutics Announces Early Clinical Data Showing Potential For SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis | CI |
| 07-08 | Seres Therapeutics, Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SERES THERAPEUTICS, INC. | Bio Therapeutic Drugs | -2.32% | -5.09% | -67.41% | -66.62% | -96.59% | 46.97M |  | | |
- Stock Market
- Stocks
- MCRB Stock
- Charts Seres Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
